Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice - PubMed (original) (raw)
Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice
Y Shimomura et al. Horm Metab Res. 1987 Jul.
Abstract
Adrenalectomy in young obese (ob/ob) and the diabetic (db/db) mouse slowed body weight gain. Treatment of adrenalectomized ob/ob mice with cortisone or deoxycorticosterone acetate (DOCA) significantly increased weight gain in a dose-related manner. Cortisone had no effect on weight gain on lean mice and treatment with dehydroepiandrosterone sulfate was without effect on either ob/ob or lean mice. The increment in body weight of adrenalectomized ob/ob mice treated with corticosterone and DOCA was associated with an increase in body weight and an increase in food intake. When adrenalectomy was performed at twenty-three days of age (five days before weaning), animals carrying the (db/db) genotype remained lighter than their normal littermates. These data document the importance of the adrenal gland and its steroids for the development and maintenance of many features of the obese or diabetes mouse.
Similar articles
- Adrenalectomy in genetically obese ob/ob and db/db mice increases the proton conductance pathway.
Shargill NS, Lupien JR, Bray GA. Shargill NS, et al. Horm Metab Res. 1989 Sep;21(9):463-7. doi: 10.1055/s-2007-1009264. Horm Metab Res. 1989. PMID: 2583669 - Adrenalectomy and food restriction in the genetically obese (ob/ob) mouse.
Saito M, Bray GA. Saito M, et al. Am J Physiol. 1984 Jan;246(1 Pt 2):R20-5. doi: 10.1152/ajpregu.1984.246.1.R20. Am J Physiol. 1984. PMID: 6421174 - Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
Bailey CJ, Day C, Bray GA, Lipson LG, Flatt PR. Bailey CJ, et al. Horm Metab Res. 1986 Jun;18(6):357-60. doi: 10.1055/s-2007-1012316. Horm Metab Res. 1986. PMID: 3525360 - Molecular mapping of obesity genes.
Friedman JM, Leibel RL, Bahary N. Friedman JM, et al. Mamm Genome. 1991;1(3):130-44. doi: 10.1007/BF00351059. Mamm Genome. 1991. PMID: 1797227 Review.
Cited by
- Distinct mechanisms involving diacylglycerol, ceramides, and inflammation underlie insulin resistance in oxidative and glycolytic muscles from high fat-fed rats.
Jani S, Da Eira D, Hadday I, Bikopoulos G, Mohasses A, de Pinho RA, Ceddia RB. Jani S, et al. Sci Rep. 2021 Sep 27;11(1):19160. doi: 10.1038/s41598-021-98819-7. Sci Rep. 2021. PMID: 34580412 Free PMC article. - G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.
Czegle I, Csala M, Mandl J, Benedetti A, Karádi I, Bánhegyi G. Czegle I, et al. World J Hepatol. 2012 Apr 27;4(4):129-38. doi: 10.4254/wjh.v4.i4.129. World J Hepatol. 2012. PMID: 22567185 Free PMC article. - The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.
Wang M. Wang M. Nutr Metab (Lond). 2005 Feb 2;2(1):3. doi: 10.1186/1743-7075-2-3. Nutr Metab (Lond). 2005. PMID: 15689240 Free PMC article. - Leptin acts in the periphery to protect thymocytes from glucocorticoid-mediated apoptosis in the absence of weight loss.
Trotter-Mayo RN, Roberts MR. Trotter-Mayo RN, et al. Endocrinology. 2008 Oct;149(10):5209-18. doi: 10.1210/en.2008-0476. Epub 2008 Jun 26. Endocrinology. 2008. PMID: 18583419 Free PMC article. - A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.
Anil TM, Dandu A, Harsha K, Singh J, Shree N, Kumar VS, Lakshmi MN, Sunil V, Harish C, Balamurali GV, Naveen Kumar BS, Gopala AS, Pratibha S, Sadasivuni M, Anup MO, Moolemath Y, Venkataranganna MV, Jagannath MR, Somesh BP. Anil TM, et al. BMC Pharmacol Toxicol. 2014 Aug 7;15:43. doi: 10.1186/2050-6511-15-43. BMC Pharmacol Toxicol. 2014. PMID: 25098735 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous